로딩 중…
지수 로딩 중…
SAMSUNG PHARMACEUTICAL.CO.,Ltd.
001360· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩1,430-3.90%
2026-06-19
Price Chart
SAMSUNG PHARMACEUTICAL.CO.,Ltd.-21.51%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 134.65B KRW |
| Revenue | 43.73B KRW |
| Net Income | -87.59B KRW |
| Total Assets | 175.35B KRW |
| Net Assets | 129.81B KRW |
| Employees | 86 |
| Value | |
| P/B | 1.04x |
| P/S | 3.08x |
| FCF Yield | -7.50% |
| Profitability | |
| ROE | -67.47% |
| ROA | -49.95% |
| Op. Margin | -6.44% |
| Revenue Growth | -20.62% |
| Earnings Growth | -76.46% |
| Financial Health | |
| Debt Ratio | 135.08% |
| Total Debt | 21.85B KRW |
| FCF | -10.10B KRW |
| Cash | 8.00B KRW |
| Current Ratio | 0.96x |
| Performance | |
| 1Y Return | -21.51% |
| 1M Return | -9.49% |
| From 52W High | -38.36% |
| 1Y MDD | -41.09% |
| Trading | |
| Volume | 906,394 shares |
| Foreign Own. | 2.56% |
| Per Share | |
| EPS | -180 KRW |
| BPS | 1,379 KRW |
Company Info
Samseong Pharmaceutical was founded as Samseong Pharmaceutical Office in 1929, incorporated in 1954, and listed on the KOSPI market in 1975. The company operates in pharmaceutical manufacturing and sales, bio business, and health food sales, holding 11 affiliated companies including its largest shareholder, GemVax & KAEL Co., Ltd. It markets over 80 product groups of specialized prescription drugs, such as antibiotics and prostate treatment drugs, via CSO marketing. Over-the-counter drugs like Kkasmyeongsu and Panto-A are supplied to pharmacies and convenience stores through an exclusive agreement with Jeil Health Science. Samseong Pharmaceutical is headquartered in Hwaseong, Gyeonggi Province.